BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 22590765)

  • 1. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders.
    Rogol AD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of growth hormone in children.
    Hindmarsh PC; Dattani MT
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current indications for growth hormone therapy for children and adolescents.
    Richmond E; Rogol AD
    Endocr Dev; 2010; 18():92-108. PubMed ID: 20523020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for growth hormone therapy in children.
    Kirk J
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues related to recombinant human growth hormone utilization and optimization in a health plan setting.
    Nickman NA; Dunn JD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS11-5. PubMed ID: 22590768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth hormone therapy].
    Krysiak R; Okopień B; Gdula-Dymek A
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of growth hormone in children and adolescents].
    Bergadá I
    Medicina (B Aires); 2013; 73(3):272-6. PubMed ID: 23732208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental syndromes: growth hormone deficiency and treatment.
    Mazzanti L; Tamburrino F; Bergamaschi R; Scarano E; Montanari F; Torella M; Ballarini E; Cicognani A
    Endocr Dev; 2009; 14():114-34. PubMed ID: 19293579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.
    Kappelgaard AM; Laursen T
    Growth Horm IGF Res; 2011 Dec; 21(6):305-13. PubMed ID: 22019012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature.
    Rodríguez Arnao MD; Sánchez AR; García-Rey C; Arroyo Díez FJ; Estrada RC; Cuartero BG; Merillas MA; López-Siguero JP;
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1201-8. PubMed ID: 25210749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
    Pawlikowska-Haddal A
    Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Indications for Growth Hormone Therapy.
    Danowitz M; Grimberg A
    Adv Pediatr; 2022 Aug; 69(1):203-217. PubMed ID: 35985710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of recombinant Human Growth Hormone (rHGH)].
    Calzada-León R
    Rev Med Inst Mex Seguro Soc; 2017; 55(2):196-213. PubMed ID: 28296370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.